Stem Cell Technology: Current Applications and Future Directions

Publication Date	June 2008
Publisher	BCC Research
Product Type	Report
Pages
ISBN Number	not applicable
Product Code	BCC00201

Price

£3,265.00
approximately: $4,849 | €3,842

PDF

Order above formats by FAX

Summary

Study Goals And Objectives

Bcc's Goal In Conducting This Study Was To Determine The Current Status Of Stem Cell Technology And Its Applications And Assess Its Growth Potential Over A 5-Year Period From 2007 To 2012. We Are Particularly Interested In The Position Of Adult Stem Cell Technology And Applications As Compared To The Development And Applications Of Embryonic Stem Cells. Additionally, We Are Interested In The Market Potential Of Emerging Breakthroughs In Stem Cell Research Such As Induced Pluripotent Stem Cells (Ips).

Our Key Objective Is To Present A Comprehensive Analysis Of The Current State Of Stem Cell Research And Development (R&D) As Well As The Current Stem Cell Market And Its Future Direction.

Reasons For Doing The Study

Stem Cell Technology Has Been Described As The Next Revolution In Medicine.

Therapeutic Stem Cell Applications Have Been Proposed To Address A Wide Range Of Health Care Needs. We Are Interested In Determining The Current State Of Stem Cell Technology, Where Stem Cells Are Currently Being Applied, And Evaluating The Potential Growth For Stem-Cell-Based Applications. In Particular, We Are Interested In Discerning The Current Technological State And Potential Growth Of Adult Stem-Cellbased Applications As Compared To Embryonic-Stem-Cell-Based Applications.

Additionally, We Are Interested In Looking Forward To Emerging Advancements In Stem Cell Technology And Evaluating The Potential Impact These Advancements Could Have On The Development Of Stem-Cell-Based Products.

Scope Of Report

This Report Encompasses The Two Major Classes Of Stem Cells: Adult And Embryonic.

Bcc Examined The Current State Of Stem Cell Technology, Focusing On These Two Major Classes As Well As Emerging Breakthroughs In Stem Cell Research And Development. Further, Bcc Evaluated The Current Stem Cell Market In The United States (U.S.) And Examined The Future Impact Of Stem-Cell-Based Technology, Presenting Forecasts Of Growth Over The Next 5 Years. Technological Issues Covering Current And Emerging Stem-Cell-Based Therapeutic Applications Are Also Reviewed.

Further Issues Considering Stem-Cell-Based Therapeutic Research And Development And Its Applications Are Additionally Discussed.

Given The Major Role That The U.S. Plays In The World Health Care Market (Both As Provider And Consumer), This Analysis Is Focused Predominantly On The Current State Of Stem Cell Technology And Its Applications In The U.S., With Some Discussion Regarding Worldwide Stem Cell Technology Impact. In Addition To Technological Considerations As Well As Market Issues, We Examine Governmental (Legal And Political) As Well As Social Issues Regarding The Research And Development Of Stemcell- Based Therapeutic Applications. The Present And Projected Status Of Stem-Cellbased Technology Is Compared For High Value Applications Of Cellular Therapeutics, Engineered Tissue For Transplantation, And Therapeutic Stem Cell Banking. Further, The Present And Projected Status Of Stem-Cell-Based Therapeutic Research Applications Are Projected For High Value Applications Such As Cell-Based Assays, Diagnostic Tools, And Necessary Support Reagents And Materials.

Intended Audience

Given The Broad Application Potential Of Stem-Cell-Based Technology, The Present Study Will Be Of Interest To The Life Science Industry, In Particular, To Individuals In The Biotechnology, Pharmaceutical, And Medical Device Markets. Further, It Will Be Of Interest To Manufacturers Of Reagents And Tools That Support The Research And Development Of Stem-Cell-Based Products And Services.

Further, This Report Will Of Be Of Interest To Professionals Presently Focused In Areas Of Stem Cell Research, Development, And Commercialization As Well As Those Surveying Potential Stem-Cell-Based Opportunities For Investment. Additionally, This Report Will Be Of Particular Interest To Health Care Professionals Surveying The Potential Therapeutic Application Of Stem-Cell-Based Technology And Its Growth.

Information Sources

Bcc Surveyed Approximately 60 Companies Directly And Actively Engaged In Stem Cell Focused Research And Product Development To Obtain Data For This Study.

Contained Within This Study Are Companies Pursuing Both Adult Stem-Cell-Based Products As Well As Embryonic-Based Stem Cell Applications. Of Particular Focus Are Companies Centered On The Development Of Cellular Therapeutics, Engineered Tissue For Transplantations, And Therapeutic Banking Of Stem Cells For Future Medical Applications. Also Surveyed Were Academic Stem Cell Researchers As Well As Life Science Industry Professionals. Additionally, Extensive Data Was Compiled From Primary Scientific Source Literature And Current Financial And Trade Information As Well As Government And Regulatory Sources, Both Federal And State.

Analyst Credentials

Bcc Analyst Dr. Steven Munevar Holds A Ph.D. In Biomedical Science And Is An Experienced Life Science Research Scientist, Having Authored High Impact, Peer Reviewed Publications Spanning Cellular Biology Through Molecular And Cellular Physiology. Further, Dr. Munevar Has A Strong Background In Bioengineering, Spanning High Technology Applications In Life Science/Health Care Settings, Biomaterials, Biomedical Devices, And Life-Science-Related Instrumentation.

Additionally, Dr. Munevar Has An Mba With A Focus On New Venture Creation, Particularly In The Life Sciences. Dr. Munevar Is Currently The President And Ceo Of Munevar And Associates, Inc., A Life Science Technology Development And Commercialization Company Focused On Moving Life Science Innovations From The Research Bench Into The Market And To The Patient Bedside.

Content

Introduction
Study Goals And Objectives
Reasons For Doing The Study
Scope Of Report
Intended Audience
- Information Sources.
Analyst Credentials
- Related Reports.
Bcc Online Services
Disclaimer
Summary
Summary Table U.S. Market For Stem Cells In
- Regenerative Medicine Revenue, Through 2012
- ($ Millions).
Summary Figure U.S. Market For Stem Cells In
- Regenerative Medicine Revenue, 2005-2012 ($ Millions)
Overview
Historical Review Of Stem Cell Biology
History Of Stem Cell Biology
Early Observation And Classifications
Stem Cell Classification
- Derivation Of Human Tissue Types During Development
- From Embryonic Stem Cells
Table Derivation Of Human Tissue Types During
Development
Figure Flow Diagram Of Human Development Process
- Derivation Of Human Tissue Following Maturation From
- Adult Stem Cells
Stem Cell Concepts In Health Care
Initial Stem Cell Isolation And
Characterization
- Initial Stem Cell Isolation (Continued)
Early Cell-Based Therapeutics
- Xeno Transplants
- Blood Transfusions And Bone Marrow Transplantation
Areas Of Health Care Need And Stem Cells
Disease- And Degeneration-Related Health Care
- Need
Organ Transplantation-Related Health Care
- Need
Cancer- And Genetic Disorder-Related Health
Care Need
Infectious Disease-Related Health Care Need
Health Care Need And Costs
- Health Care Need And Costs (Continued)
Current State Of Regenerative Medicine
Stem Cell Classification Based On Source
- Embryonic Stem Cells
- Adult (And Progenitor) Stem Cells
- Adult (And Progenitor) (Continued)
Stem Cell Classification Based On
Differentiation Potential
- Pluripotent Stem Cell Differentiation Potential
- Multipotent Stem Cell Differentiation Potential
- Unipotent Stem Cell Differentiation Potential
Table Stem Cell Classification Based On
Differentiation Potential
Dynamically Evolving Areas In Stem Cell Biology
Clonal Stem Cells Lines In Nonhuman Primates
Embryonic Stem Cell Lines Derived From Inner
Cell Mass Of Viable Embryos
Stem Cells From Neonatal Fluid
Adult Stem Sourcing/Niches
- Adult Stem Sourcing/Niches (Continued)
Table Adult Stem Cell Types And Potential Tissue
Sources
Disease-Specific Embryonic Stem Cell Lines
Adult Stem Cell Reprogramming
Personalized Health Care
- Cell-Based Therapeutics
- Using Embryonic-Derived Stem Cells
- Using Adult/Progenitor-Derived Stem Cells
Engineered Tissue For Transplantation
- Using Embryonic-Derived Stem Cells
- Using Adult Stem Cells (And Progenitor Cells)
Therapeutic Stem Cell Banking
- Stem-Cell-Based Biomedical Research
Markets For Stem-Cell-Based Cellular Therapeutics
Health Care Need And The Application Of Stem
- Cells
- Cardiovascular System-Related Clinical Stem Cell
- Applications
- Nervous System-Related Clinical Stem Cell Applications
- Skeletal/Muscular System-Related Clinical Stem Cell
- Applications
- Whole Organ (Tissue) System-Related Clinical Stem Cell
- Applications
- Stem-Cell-Related Cancer And Clinical Applications
- Infectious Disease/Cancer (General) And Clinical
- Applications
Government Regulations And The Use Of Stem Cells
In Research And Therapeutic Applications
Government Regulation Of The Application Of
- Stem-Cell-Based Therapeutics
- Government Regulation Of(Continued)
Government Regulation Of The Application Of
- Stem-Cell-Based Research
Table The National Institutes Of Health Stem Cell
- Research Funding, 2004-2009 ($ Millions)
Figure The National Institutes Of Health Human Stem
- Cell Research Funding, 2004-2009 ($ Millions)
Table The National Institutes Of Health Human
Embryonic Stem Cell Registry
Table States Funding Stem-Cell-Related Research
Future Impact Of Stem Cells On Unmet Health Care
- Need
Future Impact Of Stem
Stem Cell Technology In The Regenerative Medicine
- Market
Table Projected U.S. Growth Trend For Stem Cells In
- Regenerative Medicine, Through 2012 ($ Millions)
Figure Projected U.S. Growth Trend For Stem Cells In
- Regenerative Medicine, 2005-2012 ($ Millions)
Introduction To Stem Cells Technology In
Regenerative Medicine Market
Stem Cells In Cellular Therapeutics
- Stem Cells In Cellular Therapeutics (Continued)
- Stem Cells In Cellular Therapeutics (Continued)
Figure Flow Diagram Of Process Using Stem Cells In
Cellular Therapeutics
- Stem Cells In Cellular Therapeutics (Continued)
Table Projected U.S. Growth Trend For Stem Cells In
- Cell-Based Therapeutics For Human Adult And
- Embryonic Stem Cells, Through 2012 ($ Millions)
Figure Projected U.S. Growth Trend For Stem Cells In
- Cell-Based Therapeutics For Human Adult And
- Embryonic Stem Cells, 2005-2012 ($ Millions)
- Stem Cells In Cellular Therapeutics Towards Engineering
- Tissue In Vitro For Transplantation
- Stem Cells In Cellular Therapeutics (Continued)
- Stem Cells In Cellular Therapeutics (Continued)
Figure Flow Diagram Of Process Using Stem Cells In
Engineering Tissue For Transplantation
Therapeutic Stem Cell Banking
Figure Flow Diagram For Process Of Therapeutic
Banking Of Stem Cells
- Therapeutic Stem Cell Banking (Continued)
Table Projected U.S. Growth Trend For Therapeutic
- Stem Cell Banking, Through 2012 ($ Millions)
Figure Projected U.S. Growth Trend For Therapeutic
- Stem Cell Banking, 2005-2012 ($ Millions)
Introduction To Stem Cells Technology In
Therapeutic-Related Research
Stem Cell Technology In Cell-Based Assays And
Diagnostic Research Applications
Table Projected U.S. Growth Trend For Stem-Cellrelated
- Therapeutic Research ($ Millions)
Figure Projected U.S. Growth Trend For Stem-Cellrelated
- Therapeutic Research, 2005-2012 ($ Millions)
Therapeutic Stem-Cell-Related Research
Support
Table Projected U.S. Growth Trend For Stem-Cellrelated
- Cell-Based Assays/Diagnostics Therapeutic
- Research By Segment, Through 2012 ($ Millions)
Figure Projected U.S. Growth Trend For Stem-Cellrelated
- Cell-Based Assays/Diagnostics Therapeutic
- Research By Segment, 2005-2012 ($ Millions)
Factors Driving And Inhibiting Application Of
Stem Cell Technology
- Factors Driving And Inhibiting (Continued)
- Factors Driving And Inhibiting (Continued)
- Factors Driving And Inhibiting (Continued)
Table Factors Driving And Inhibiting The Application
Of Stem-Cell-Based Therapeutics
Markets By Types Of Applications
Introduction To Stem-Cell-Therapeutic-Based
Applications
Stem Cell Applications: Regenerative Medicine
- Stem Cell Applications Specifically By Tissue Type
- Stem Cell Applications Specifically By Organ System Type
- Stem Cell Applications In Infectious Disease, Genetic
- Disorders, And Cancer-Related
Table Stem Cell Technology Applications In
Regenerative Medicine
Stem Cell Applications In Research And
Development
- Stem Cell Applications In Academic Research
- Stem Cell Applications In Biotechnology And Medical
- Device Research
- Stem Cells In Pharmaceutical Research
Table Stem Cell Technology Areas Of Application
Within The Life Sciences
Stem Cell Technology And Development
Stem Cell Production
Stem Cell Acquisition
Characterization And Expansion
Maintenance And Storage
Figure Flow Diagram For Process Of Stem Cell
Production
Stem Cell Production Economics
Stem Cell Production Economics
Novel Stem Cell Production Developments
Isolation And Engineering
Novel Developments In The Production Of Adult
Stem Cells
Novel Developments In The Production Of
Embryonic Stem Cells
- Novel Developments In The Production (Continued)
Leaders In Stem Cell Research Development
Academic Research And Development Leaders
- Academic Stem Cell Research And Development Scientists
- George Q. Daley, Md, Ph.D
- Kevin Eggan, Ph.D
- Doug Melton, Ph.D
- Amy Wagers, Ph.D
- Robert Langer, Sc.D
- Irving Weissman, Md
- Stuart Orkin, Md
- Joseph Vacanti, Md
- Kenneth Chien, Md, Ph.D
- Rudolf Jaenisch, Md
- Daniel Tenen, Md
- Konrad Hochedlinger, Ph.D
- Paul Matsudaira, Ph.D
- Anthony Atala, Md
- Elaine Fuchs, Ph.D
- David J. Mooney, Ph.D
- James A. Thomson, Ph.D
- Shinya Yamanaka, Md, Ph.D
- Kacey G. Marra, Ph.D
- Gordon Keller, Ph.D
- Johnny Huard, Ph.D
- Hans Keirstead, Ph.D
- Shoukhrat Mitalipov, Ph.D
- Gordon Keller, Ph.D
- Table Highlighted Stem Cell Research Publications,
- 2005-2008
Industry Research And Development Leaders
Technology Patent Analysis
General Trends
- Table Stem Cell Patent Trends, 2000-2008
- Figure Stem Cell Patent Trends, 2000-2008
Trends By Country
- Table Stem Cell Patent Country Codes, 2000-2008
- Table Stem Cell Patent Trends By Country, 2000-2008
Table Stem Cell Patent Trends By Country Of
- Patents, 2000-2008 (%)
Figure Stem Cell Patent Trends By Country % Of
- Patents, 2000-2008 (%)
Trends By Companies
Table Stem Cell Patent Trends By Companies
- Assigned Two Or More Patents, 2000-2008
Stem Cell Industry Structure
Driving Forces In Stem-Cell-Based Industries
Driving Forces In The Health Care Market
Biotechnology
Pharmaceutical
Competitive Advantages In Stem-Cell-Based
Industries
Technology Development And Utilization
- Cost Of New Product Development,
Manufacturing, And Launch
- Cost Of New Product Development, (Continued)
Market Positioning And Capture
- Market Positioning And Capture (Continued)
- Market Positioning And Capture (Continued)
Important Shifts In Industry
Continuously Evolving Technological Base
- Continuously Evolving Technological Base (Continued)
Effects Of Fluctuations In Federal Government
And Food And Drug Administration
Regulatory Factors
Table Restrictions On Stem Cell Research By State
- Food And Drug Administration Approval Requirements
- For Implementation Of Stem-Cell-Based Therapeutics
Stage Of Stem Cell Life Cycle
- Table Total Number Of Stem Cell Clinical Trials, 2000-
- 2008
- Figure Total Number Of Stem Cell Clinical Trials,
- 2000-2008
Table Total Number Of Stem Cell Clinical Trials
- Funded By Industry, 2000-2008
Figure Total Number Of Stem Cell Clinical Trials
- Funded By Industry, 2000-2008
Table Stem Cell Clinical Trials Related To Cancer
- (Peripheral Blood/Bone Marrow Transplantation),
- 2000-2008 (%)
Figure Stem Cell Clinical Trials Related To Cancer
- (Peripheral Blood/Bone Marrow Transplantation),
- 2000-2008 (%)
Impact On Existing Health Care Market May Be
Significant
Major Stem Cell Companies
Major Stem Cell Markets
- Stem Cell Market Segmentation
- Stem Cell Market Forces
- Stem Cell Market Forces (Continued)
General Stem Cell Technology Issues
Stem Cell Technology Issues By Technology
- Type
- Embryonic Stem Cells
- Adult Stem Cells
Stem Cell Companies Percent Market Share
- Stem Cell Companies Percent Market Share (Continued)
Table Market Share Of Stem Cell Therapeutics (And
- Banking) Companies, 2005-2007 (%)
Company Profiles
Aastrom Biosciences, Inc
Table Aastrom Biosciences, Inc. Stem Cell Clinical
- Trials
Table Aastrom Biosciences, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Aldagen, Inc
Table Aldagen, Inc. Stem Cell Clinical Trials
Table Aldagen, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Advanced Cell Technology, Inc
Table Advanced Cell Technology, Inc. Stem Cell
Clinical Trials
Table Advanced Cell Technology, Inc. Stem Cell
Patents Issued Or Exclusively Licensed
Arteriocyte, Inc
Table Arteriocyte, Inc. Stem Cell Clinical Trials
Athersys, Inc
Bd Biosciences
- Bio-Matrix Scientific Group, Inc
- Bioe
Table Bioe Stem Cell Patents Issued Or Exclusively
Licensed
Bioheart, Inc
Table Bioheart, Inc. Stem Cell Clinical Trials
Table Bioheart, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Celgene Corp
Cellerant Therapeutics, Inc
Table Cellerant Therapeutics, Inc. Stem Cell
Clinical Trials
Table Cellerant Therapeutics, Inc. Stem Cell
Patents Issued Or Exclusively Licensed
Cellular Dynamics International, Inc
Cognate Bioservices, Inc
Table Cognate Bioservices, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
- Cryo-Cell International, Inc
Cytomatrix, Llc
Table Cytomatrix, Llc Stem Cell Patents Issued Or
Exclusively Licensed
Cytori Therapeutics, Inc
Table Cytori Therapeutics, Inc. Stem Cell Clinical
- Trials
Table Cytori Therapeutics, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Endgenitor Technologies, Inc
Forticell Bioscience, Inc
Table Forticell Bioscience, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Geron Corp
Table Geron Corp Stem Cell Patents Issued Or
Exclusively Licensed
Healtheuniverse, Inc
Table Healtheuniverse, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
International Stem Cell Corporation
Invitrogen Corporation
Mattek Corporation
Table Mattek Corp Stem Cell Patents Issued Or
Exclusively Licensed
Medistem Laboratories, Inc
Table Medistem Laboratories, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
- Medra, Inc
Millipore
Morphogenesis, Inc
Table Morphogenesis, Inc. Stem Cell Patents Issued
Or Exclusively Licensed
Mg Biotherapeutics, Llc
Moraga Biotechnology Corporation
Neostem, Inc
Table Neostem, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Neuralstem, Inc
Table Neuralstem, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Neurogeneration
Neuronyx, Inc
Table Neuronyx, Inc. Stem Cell Clinical Trials
Table Neuronyx, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Nutech Medical, Inc
Novocell, Inc
Table Novocell, Inc Stem Cell Clinical Trials
Table Novocell, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Opexa Therapeutics, Inc
Table Opexa Therapeutics, Inc. Stem Cell Clinical
- Trials
Organogenesis, Inc
Table Organogenesis, Inc. Stem Cell Clinical Trials
Table Organogenesis, Inc. Stem Cell Patents Issued
Or Exclusively Licensed
Osiris Therapeutics, Inc
Table Osiris Therapeutics, Inc. Stem Cell Clinical
- Trials
Table Osiris Therapeutics, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Pharmastem Therapeutics, Inc
Table Pharmastem Therapeutics, Inc. Stem Cell
Patents Issued Or Exclusively Licensed
Primegen Biotech, Llc
Progenitor Cell Therapy, Llc
Regenetech, Inc
Table Regenetech, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Saneron Ccel Therapeutics, Inc
Stem Cell Innovations
Table Stem Cell Innovations Stem Cell Patents
Issued Or Exclusively Licensed
Stem Cells, Inc
Table Stem Cells, Inc. Stem Cell Clinical Trials
Table Stem Cells, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Stem Cell Therapy International Corp
Stemcell Pharma, Inc
Stemcyte, Inc
Stemedica Cell Technologies, Inc
Tengion, Inc
Table Tengion, Inc. Stem Cell Clinical Trials
Theradigm, Inc
Table Theradigm, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Thermogenesis Corp
Vesta Therapeutics, Inc
Table Vesta Therapeutics, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Viacell, Inc
Table Viacell, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Viacord
Vistagen Therapeutics, Inc
Table Vistagen Therapeutics, Inc. Stem Cell Clinical
- Trials
Table Vistagen Therapeutics, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Vitro Diagnostics, Inc
- Vitro Diagnostics, Inc.
International Aspects Of Regenerative Medicine/Stem
Cell Market
International Aspects Of
Table Leading Global Regenerative Medicine/Stem
Cell Companies
References
Appendix A Abbreviations
Appendix B Glossary
Appendix B Glossary
Appendix B Glossary
Appendix B Glossary
- Appendix C Stem Cell Patents, 2000-2008
- Table Stem Cell Patents Between The Years 2000 And 2008
List Of Tables
Summary Table U.S. Market For Stem Cells In
- Regenerative Medicine Revenue, Through 2012
- ($ Millions) .
Table Derivation Of Human Tissue Types During
Development
Table Stem Cell Classification Based On
Differentiation Potential
Table Adult Stem Cell Types And Potential Tissue Sources
Table The National Institutes Of Health Stem Cell
- Research Funding, 2004-2009 ($ Millions)
Table The National Institutes Of Health Human
Embryonic Stem Cell Registry
Table States Funding Stem-Cell-Related Research
Table Projected U.S. Growth Trend For Stem Cells In
- Regenerative Medicine, Through 2012 ($ Millions)
Table Projected U.S. Growth Trend For Stem Cells In
- Cell-Based Therapeutics For Human Adult And
- Embryonic Stem Cells, Through 2012 ($ Millions)
Table Projected U.S. Growth Trend For Therapeutic
- Stem Cell Banking, Through 2012 ($ Millions)
Table Projected U.S. Growth Trend For Stem-Cellrelated
- Therapeutic Research ($ Millions)
Table Projected U.S. Growth Trend For Stem-Cellrelated
- Cell-Based Assays/Diagnostics Therapeutic
- Research By Segment, Through 2012 ($ Millions)
Table Factors Driving And Inhibiting The Application
Of Stem-Cell-Based Therapeutics
Table Stem Cell Technology Applications In
Regenerative Medicine
Table Stem Cell Technology Areas Of Application
Within The Life Sciences
- Table Highlighted Stem Cell Research Publications,
- 2005-2008
- Table Stem Cell Patent Trends, 2000-2008
- Table Stem Cell Patent Country Codes, 2000-2008
- Table Stem Cell Patent Trends By Country, 2000-2008
- Table Stem Cell Patent Trends By Country Of Patents,
- 2000-2008 (%)
Table Stem Cell Patent Trends By Companies Assigned
- Two Or More Patents, 2000-2008
Table Restrictions On Stem Cell Research By State
- Table Total Number Of Stem Cell Clinical Trials, 2000-
- 2008
Table Total Number Of Stem Cell Clinical Trials
- Funded By Industry, 2000-2008
Table Stem Cell Clinical Trials Related To Cancer
- (Peripheral Blood/Bone Marrow Transplantation), 2000-
- 2008 (%)
Table Market Share Of Stem Cell Therapeutics (And
- Banking) Companies, 2005-2007 (%)
Table Aastrom Biosciences, Inc. Stem Cell Clinical
- Trials
Table Aastrom Biosciences, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Table Aldagen, Inc. Stem Cell Clinical Trials
Table Aldagen, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Advanced Cell Technology, Inc. Stem Cell
Clinical Trials
Table Advanced Cell Technology, Inc. Stem Cell
Patents Issued Or Exclusively Licensed
Table Arteriocyte, Inc. Stem Cell Clinical Trials
Table Bioe Stem Cell Patents Issued Or Exclusively
Licensed
Table Bioheart, Inc. Stem Cell Clinical Trials
Table Bioheart, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Cellerant Therapeutics, Inc. Stem Cell Clinical
- Trials
Table Cellerant Therapeutics, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Table Cognate Bioservices, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Table Cytomatrix, Llc Stem Cell Patents Issued Or
Exclusively Licensed
Table Cytori Therapeutics, Inc. Stem Cell Clinical
- Trials
Table Cytori Therapeutics, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Table Forticell Bioscience, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Table Geron Corp Stem Cell Patents Issued Or
Exclusively Licensed
Table Healtheuniverse, Inc. Stem Cell Patents Issued
Or Exclusively Licensed
Table Mattek Corp Stem Cell Patents Issued Or
Exclusively Licensed
Table Medistem Laboratories, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Table Morphogenesis, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Neostem, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Neuralstem, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Neuronyx, Inc. Stem Cell Clinical Trials
Table Neuronyx, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Novocell, Inc Stem Cell Clinical Trials
Table Novocell, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Opexa Therapeutics, Inc. Stem Cell Clinical
- Trials
Table Organogenesis, Inc. Stem Cell Clinical Trials
Table Organogenesis, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Osiris Therapeutics, Inc. Stem Cell Clinical
- Trials
Table Osiris Therapeutics, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Table Pharmastem Therapeutics, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Table Regenetech, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Stem Cell Innovations Stem Cell Patents Issued
Or Exclusively Licensed
Table Stem Cells, Inc. Stem Cell Clinical Trials
Table Stem Cells, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Tengion, Inc. Stem Cell Clinical Trials
Table Theradigm, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Vesta Therapeutics, Inc. Stem Cell Patents Issued
Or Exclusively Licensed
Table Viacell, Inc. Stem Cell Patents Issued Or
Exclusively Licensed
Table Vistagen Therapeutics, Inc. Stem Cell Clinical
- Trials
Table Vistagen Therapeutics, Inc. Stem Cell Patents
Issued Or Exclusively Licensed
Table Leading Global Regenerative Medicine/Stem Cell
Companies
Table Stem Cell Patents Between The Years 2000 And
- 2008
List Of Figures
Summary Figure U.S. Market For Stem Cells In
- Regenerative Medicine Revenue, 2005-2012 ($ Millions).
Figure Flow Diagram Of Human Development Process
Figure The National Institutes Of Health Human Stem
- Cell Research Funding, 2004-2009 ($ Millions)
Figure Projected U.S. Growth Trend For Stem Cells In
- Regenerative Medicine, 2005-2012 ($ Millions)
Figure Flow Diagram Of Process Using Stem Cells In
Cellular Therapeutics
Figure Projected U.S. Growth Trend For Stem Cells In
- Cell-Based Therapeutics For Human Adult And
- Embryonic Stem Cells, 2005-2012 ($ Millions)
Figure Flow Diagram Of Process Using Stem Cells In
Engineering Tissue For Transplantation
Figure Flow Diagram For Process Of Therapeutic
Banking Of Stem Cells
Figure Projected U.S. Growth Trend For Therapeutic
- Stem Cell Banking, 2005-2012 ($ Millions)
Figure Projected U.S. Growth Trend For Stem-Cellrelated
- Therapeutic Research, 2005-2012 ($ Millions)
Figure Projected U.S. Growth Trend For Stem-Cellrelated
- Cell-Based Assays/Diagnostics Therapeutic
- Research By Segment, 2005-2012 ($ Millions)
Figure Flow Diagram For Process Of Stem Cell
Production
- Figure Stem Cell Patent Trends, 2000-2008
Figure Stem Cell Patent Trends By Country % Of
- Patents, 2000-2008 (%)
- Figure Total Number Of Stem Cell Clinical Trials, 2000-
- 2008
Figure Total Number Of Stem Cell Clinical Trials
- Funded By Industry, 2000-2008
Figure Stem Cell Clinical Trials Related To Cancer
- (Peripheral Blood/Bone Marrow Transplantation), 2000-
- 2008 (%)